Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results
Bio-Techne (NASDAQ: TECH) has scheduled its fourth quarter and fiscal 2025 financial results conference call for August 6, 2025, at 8:00 a.m. CDT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Bio-Techne (NASDAQ: TECH) has scheduled its fourth quarter and fiscal 2025 financial results conference call for August 6, 2025, at 8:00 a.m. CDT. The company will host both a conference call and webcast to discuss the results.
Investors can access the call through a toll-free number (1-800-274-8461) or international number (1-203-518-9814) using Conference ID: TECHQ4. A webcast will be available on the company's investor relations website. For those unable to attend live, a replay will be accessible until September 6, 2025, using Conference ID 11159590.
Details
News Market Reaction – TECH
The recorded move for TECH in the trading session of this news was +2.90%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Access to the discussion may be obtained as follows:
Time: | 8:00 a.m. CDT |
Date: | August 6, 2025 |
Dial-in: | 1-800-274-8461 or 1-203-518-9814 (for international callers) |
Conference ID: | TECHQ4 |
Webcast: |
A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 11159590.
The replay will be available from 11:00 a.m. CDT on Wednesday, August 6, 2025, until 11:00 p.m. CDT on Saturday, September 6, 2025.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
Contact: David Clair, Vice President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-august-6-2025-to-announce-fourth-quarter-and-fiscal-2025-financial-results-302506465.html
SOURCE Bio-Techne Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.